646. Subgroup Analyses of Microbiological Cure Rates by Baseline Zoliflodacin MIC and Susceptibility to Ciprofloxacin in Participants from the Global Zoliflodacin Phase 3 Randomized Controlled TrialSarah M. McLeod, Alison Luckey, Khurram Rana et al.|Open Forum Infectious Diseases|2026Cited by 1
P-1206. Association of Sex Assigned at Birth and Sexual Orientation with Antimicrobial Susceptibility of Baseline Neisseria gonorrhoeae Isolates from Participants Recruited in the Global Zoliflodacin Phase 3 Randomized Controlled TrialSarah M. McLeod, Alison Luckey, Esther Bettiol et al.|Open Forum Infectious Diseases|2026Cited by 0